3164 Jingyue Biotech Announces Commitments Made Upon Transfer from TPEx to TWSE and Implementation Status

Release Date: July 7, 115 Statement Date: July 6, 115 Statement Time: 17:00 Company Code: 3164 Company Name: Jingyue Biotechnology Co., Ltd.

Subject: Announcement of Commitments Made by the Company upon Application for Transfer from TPEx to TWSE and Subsequent Implementation Status

Applicable Clause: Clause 51 Factual Date: July 6, 115

Details: 1. Factual Date: July 6, 115 2. Company Name: Jingyue Biotechnology Co., Ltd. 3. Relationship with Company (Please enter '本公司' or 'Subsidiary'):本公司 (Our Company) 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: In accordance with the regulations stipulated in the letter No. 0990000468 issued by the Taiwan Stock Exchange Corporation on January 8, Republic of China 99 (2010), this announcement discloses the commitments made by the Company at the time of its initial listing and their implementation status as of the second quarter of year 115.

6. Response Measures: The Company commits that if financial statements of its significant subsidiaries are audited by other certified public accountants and such audits are used to recognize investment gains/losses or prepare consolidated financial statements, the Company's signing auditor must issue an audit opinion report that does not refer to the work of other auditors.

Subsequent Implementation Status: As of June 30, 115, there has been no such occurrence.

7. Other Matters to be Disclosed: None.